• Subacute cutaneous lupus erythematosus (SCLE) is a nonscarring, non-atrophy-producing, photosensitive dermatosis. (medscape.com)
  • other subtypes include acute cutaneous lupus erythematosus (ACLE) and chronic cutaneous lupus erythematosus. (medscape.com)
  • Chronic cutaneous lupus erythematosus includes discoid lupus erythematosus (DLE), lupus erythematous panniculitis/profundus, lupus tumidus, and chilblain lupus. (medscape.com)
  • SCLE may occur in patients with systemic lupus erythematosus (SLE), Sjögren syndrome , deficiency of the second component of complement (C2d), or it may be drug-induced. (medscape.com)
  • Early lesions of subacute cutaneous lupus erythematosus may simulate polymorphous light eruption. (medscape.com)
  • Subacute cutaneous lupus erythematosus (SCLE) occurs in genetically predisposed individuals, most often in patients with human leukocyte antigen B8 (HLA-B8), human leukocyte antigen DR3 (HLA-DR3), human leukocyte antigen DRw52 (HLA-DRw52), and human leukocyte antigen DQ1 (HLA-DQ1). (medscape.com)
  • One study demonstrated that patients with SCLE, as well as those with discoid lupus erythematosus, but not those with lupus tumidus, have elevated levels of type I interferon-regulated genes in their blood. (medscape.com)
  • Systemic lupus erythematosus is a chronic, multisystem, inflammatory disorder of autoimmune etiology, occurring predominantly in young women. (merckmanuals.com)
  • Systemic lupus erythematosus (SLE) is more common and severe among Black and Asian patients than among White patients. (merckmanuals.com)
  • Dr. Putterman's major research interests are in the field of immunology and autoimmune diseases, and specifically the identification and characterization of novel mechanisms, biomarkers, and treatment approaches to immune mediated nephritis, neuropsychiatric lupus, and systemic lupus erythematosus. (biu.ac.il)
  • Systemic lupus erythematosus with membranous lupus nephritis. (ocu-radiology.jp)
  • Systemic lupus erythematosus (SLE) is a complex connective tissue disorder that involves multiple organs. (bmj.com)
  • Lupus erythematosus was first described and distinguished from lupus vulgaris by Cazenave and Schedel in 1833. (bmj.com)
  • The diagnosis of systemic lupus erythematosus (SLE) must be based on the proper constellation of clinical findings and laboratory evidence. (medscape.com)
  • OBJECTIVE: To determine the degree of correlation between Farr and ELISA methods of detecting anti-dsDNA antibodies in patients with systemic lupus erythematosus (SLE), and their association with measures of disease activity. (jrheum.org)
  • Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that can affect any organ or body system. (vannuysdisability.com)
  • Systemic lupus erythematosus (SLE) is an autoimmune disease. (vannuysdisability.com)
  • Systemic lupus erythematosus (lupus) is a chronic (long-lasting) autoimmune disease that can affect many parts of the body. (iqscloud.net)
  • Objective To compare clinical and laboratory characteristics between systemic lupus erythematosus (SLE) patients with and without cutaneous vasculitis ,and to investigate the correlation of cutaneous vasculitis with severe visceral involvement and laboratory biomarkers . (bvsalud.org)
  • The aim of this study was to evaluate the efficacy of MTX in a particular group of patients with systemic lupus erythematosus (SLE). (bmj.com)
  • 1 The first data concerning successful use of MTX in systemic lupus erythematosus (SLE) were published as early as 1965 by Miescher et al 2 but it is only recently that interest has grown. (bmj.com)
  • Intriguingly, many of these polymorphisms are shared with other rheumatic diseases, such as systemic lupus erythematosus. (hindawi.com)
  • Neonatal lupus erythematosus presents group of autoimmune disorders that results from either congenital trans-placental passage of antinuclear and ribonuclear autoantibodies targeting fetal and neonatal tissues (Neonatal Lupus Syndromes( or to less extent from infant's intrinsic deregulated immune system (Primary infantile SLE). (heraldopenaccess.us)
  • However, only 1% of infants with positive maternal autoantibodies develop neonatal lupus erythematosus and some cases are born to asymptomatic mothers who are unaware of their autoimmune disorders and get their sero-positivity discovered after an affected infant. (heraldopenaccess.us)
  • Neonatal lupus erythematosus is an uncommon disease described mainly in isolated case reports. (heraldopenaccess.us)
  • Neonatal lupus erythematosus occurs in 1 of every 20,000 American live births and in 0.6 of every 100,000 children annually. (heraldopenaccess.us)
  • The presence of human leukocyte antigen B8 (HLA-B8) and human leukocyte antigen DR3 (HLA-DR3) in the mother predisposes the infant to neonatal lupus erythematosus and congenital heart block. (heraldopenaccess.us)
  • Lupus erythematosus of childhood appears to be more common in black, Latin American, and Asian children (3:1 ratio in all races compared with white patients). (heraldopenaccess.us)
  • Female infants have two to three times' higher incidence for developing cardiac and cutaneous neonatal lupus erythematosus compared to male infants. (heraldopenaccess.us)
  • This results in multiorgan damage that manifests as nephritis, vasculitis and arthritis. (bmj.com)
  • 15 The key role of aberrant B cell autoreactivity in SLE was revealed in a landmark murine study using a knockout gene mutation to prevent lupus mice from developing B cells, which resulted in a lack of autoantibody formation and clinical manifestations (nephritis or vasculitis). (bmj.com)
  • [ 7 ] According to the revision, a patient is classified as having SLE if the patient has biopsy-proven lupus nephritis with ANA or anti-dsDNA antibodies or if the patient satisfies 4 of the diagnostic criteria (see below), including at least 1 clinical and 1 immunologic criterion. (medscape.com)
  • Also in 2012, the ACR published " Guidelines for the Screening, Diagnosis, Treatment and Monitoring of Lupus Nephritis in Adults ," as well as an evidence report for lupus nephritis . (medscape.com)
  • Every week, we run two Lupus Clinics, allowing us to see 40-50 lupus patients/week, half of them with lupus nephritis. (sleuro.org)
  • Lupus nephritis is our main clinical research topic, with more than 50 publications in this specific field dealing with the diagnosis, prognosis and treatment of renal involvement. (sleuro.org)
  • Our group designed and run two European investigator-initiated trials which helped to define the optimal therapy of lupus nephritis. (sleuro.org)
  • Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis. (sleuro.org)
  • Disease severity of proliferative lupus nephritis in Maghrebians. (sleuro.org)
  • A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis : data from the MAINTAIN Nephritis Trial. (sleuro.org)
  • Prediction of prognosis and renal outcome in lupus nephritis. (sleuro.org)
  • Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis. (sleuro.org)
  • This is called lupus nephritis. (iqscloud.net)
  • In lupus nephritis 11-13 several well conducted studies have shown the benefit of cyclophosphamide and corticosteroids and this is the established regimen nowadays. (bmj.com)
  • Common manifestations may include arthralgias and arthritis, Raynaud syndrome, malar and other rashes, pleuritis or pericarditis, renal or central nervous system involvement, and autoimmune cytopenias. (merckmanuals.com)
  • Relationships between the 2 assays and measures of disease activity [SLE Disease Activity Index 2000 (SLEDAI-2K-DNA), renal, central nervous system (CNS), and vasculitis] were determined for the same clinic visit. (jrheum.org)
  • Farr levels were significantly associated with the presence of renal disease and vasculitis, while ELISA levels were not. (jrheum.org)
  • The Farr is superior to the ELISA in correlating with measures of global disease activity, as well as renal and vasculitis involvement. (jrheum.org)
  • Patients with renal and central nervous involvement were excluded from the study. (bmj.com)
  • 18 years of age were enrolled this study with diagnosis of cPACNS if they had: a clinical symptoms compatible with primary CNS vasculitis, and MRA findings demonstrating arterial stenosis and or aneurism that are not attributable to other disease and background. (fortuneonline.org)
  • Patients with SLE may present with any combination of clinical features and serologic evidence of lupus. (medscape.com)
  • BACKGROUND: Feature selection is a critical step for translating advances afforded by systems-scale molecular profiling into actionable clinical insights. (bvsalud.org)
  • Our Lupus Center is dedicated to clinical care of lupus patients and to translational and clinical research, with a strong cross-fertilization approach. (sleuro.org)
  • This paper reviews the current understanding about the assessment tools (i.e., clinical features, laboratory tests, radiologic assessments, etc.) widely used for evaluation of the disease activity and damage status of the children with vasculitis. (cyberleninka.org)
  • Because PAN, WG, and TA affect many body systems, they have a wide range of clinical presentation and, if left untreated, follow a chronic relapsing course with high mortality and morbidity. (cyberleninka.org)
  • I wanted to have a different look on the way to manage patients with vasculitis and conduct clinical research than that I gained during the past eight years working in France with Professor Guillevin and the French Vasculitis Study Group. (vasculitisfoundation.org)
  • Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. (medscape.com)
  • He was awarded the degree of MD from the University of Bristol for his work on Central Nervous System Inflammatory Disorders including Multiple Sclerosis, Cerebral lupus, Cerebral Vasculitis, Neurosarcoidosis, and Neuro-Behçet's disease. (nuffieldhealth.com)
  • Dr Joseph has presented research work nationally and internationally covering the Central Nervous System Inflammatory Disorders including Multiple Sclerosis, Cerebral lupus, Cerebral Vasculitis, Neurosarcoidosis, and Neuro-Behçet's disease. (nuffieldhealth.com)
  • Taking into account that the increase in cAMP levels has an important impact on immunosuppressive and anti-inflammatory properties, selective inhibitors of PDEs have been widely studied for the treatment of certain pathologies such as immunological disorders, inflammatory processes and disorders of the central nervous system. (justia.com)
  • Vasculitis is a heterogeneous group of blood vessels disorders which characterized by inflammation, necrosis and the obstruction of the inflamed vessels [1]. (fortuneonline.org)
  • His initial diagnosis was cerebral vasculitis based on computed tomography displaying bilateral vasogenic oedema, a 4 mm midline shift and a right thalamic lacunar infarct. (touchneurology.com)
  • He was subsequently hospitalized at a rural hospital with an initial diagnosis of cerebral vasculitis based on computed tomography (CT) imaging showing bilateral vasogenic oedema, a 4 mm midline shift and a right thalamic lacunar infarct. (touchneurology.com)
  • 300 CD4+ cells/mm3 who presented with five episodes of recurrent meningitis, focal subarachnoid hemorrhage and cerebral vasculitis ultimately attributed to Salmonella choleraesuis infection. (openaidsjournal.com)
  • Computed tomography and magnetic resonance imaging have aided the characterization of central nervous system lesions, and cerebral angiograms have pointed to vasculitis as a part of disease pathogenesis. (hindawi.com)
  • CNS vasculitis can cause brain damage with reversible and or irreversible neurologic involvement, including acute ischemic attack, progressive cognitive decline and seizures often with intractable pattern. (fortuneonline.org)
  • Nervous system involvement resulting in inflammation of the central nervous system-spinal cord and brain. (vannuysdisability.com)
  • Childhood systemic vasculitides are a group of rare diseases with multi-organ involvement and potentially devastating consequences. (cyberleninka.org)
  • Men, African Americans, Chinese people, and Hispanic people are also more likely to have serious organ system involvement. (iqscloud.net)
  • LS is traditionally considered to be limited to skin, subcutaneous tissue, underlying bone, and, in craniofacial subtype, nervous system involvement [ 1 ]. (hindawi.com)
  • Brachial neuritis is defined as dysfunction limited to the upper extremity nerve plexus (i.e., its trunks, division, or cords) without involvement of other peripheral (e.g., nerve roots or a single peripheral nerve) or central (e.g., spinal cord) nervous system structures. (cdc.gov)
  • Apart from its use in rheumatoid arthritis, MTX has been assessed in small studies in patients with vasculitis, uveitis, and inflammatory bowel disease. (bmj.com)
  • Methotrexate (MTX) has been successfully used in several rheumatological diseases, such as rheumatoid arthritis, psoriatic arthritis, Reiter's syndrome, and more recently vasculitis. (bmj.com)
  • Central nervous system (CNS) vasculitis of childhood is a novel recognized autoimmune brain disorder with significant diagnostic and therapeutic challenges [2,3]. (fortuneonline.org)
  • After establishment of new classification criteria (Ankara consensus conference in 2008), it is now time to establish measures for proper definition of activity and damage in childhood primary vasculitis. (cyberleninka.org)
  • By comparison to adult vasculitis, there is no consensus for indices of activity and damage assessment in childhood vasculitis. (cyberleninka.org)
  • After defining the classification criteria for primary systemic childhood vasculitis, the next step was to perform a validation study using the original Birmingham vasculitis activity score as well as the disease extent index to measure disease activity in childhood vasculitis. (cyberleninka.org)
  • With the wider use of immunosuppressive agents, both mortality and morbidity rates have been declining in childhood vasculitides [2]. (cyberleninka.org)
  • Most often it happens in people between ages 15 and 45 years, but lupus can occur in childhood or later in life as well. (iqscloud.net)
  • EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. (medscape.com)
  • Overview of Systemic Lupus. (merckmanuals.com)
  • The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the ACR SLE classification criteria in 2012. (medscape.com)
  • Neonatal lupus syndromes (NLS) occurs in infants born to mother with rheumatic conditions including systemic lupus erythematous (SLE), Sjögren's disease, mixed connective tissue disease, leukocytoclastic vasculitis, various forms of arthritis, immune-mediated thrombocytopenia, thyroiditis, autoimmune hepatitis, and undifferentiated autoimmune syndromes. (heraldopenaccess.us)
  • The cause of lupus is unknown, and researchers are still trying to learn what may trigger or lead to the disease. (iqscloud.net)
  • Due to the heterogeneous and non specific manner that vasculitis can present there is often a delay in diagnosis which translates to increase morbidity and mortality. (eurekaselect.com)
  • We provide a brief summary of how a diagnosis of vasculitis is currently made, describe how increased understanding of disease mechanisms has identified biomarkers which aid diagnosis, and describe how clinically applicable diagnostic criteria could be developed. (eurekaselect.com)
  • Furthermore, the levels were correlated with the patients' cutaneous disease activity severity levels as measured by the Cutaneous Lupus Area and Severity Index (CLASI). (medscape.com)
  • Any combination of organ systems can be involved in a particular individual, in any degree of severity. (vannuysdisability.com)
  • This commonly includes evaluation of antibodies to dsDNA, complement, and ANA subtypes such as Sm, SSA, SSB, and ribonucleoprotein (RNP) (often called the ENA panel), as well as screening anticardiolipin antibodies, lupus anticoagulant, and +/- beta-2 glycoprotein antibodies. (medscape.com)
  • Digestive problems such as abnormal contractions of the esophagus (dysmotility) or inflammation of arteries (vasculitis) supplying organs of the gastrointestinal system, resulting in pancreatitis, intestinal obstruction, abdominal pain, ulcers, weight loss, or death of intestinal tissue (intestinal infarction) requiring surgical intervention. (vannuysdisability.com)
  • Doctors know that it is a complex autoimmune disease in which the body's immune system attacks the person's tissues and organs. (iqscloud.net)
  • Most lupus polyarthritis is nondestructive and nondeforming. (merckmanuals.com)
  • Patients had one or more of the following manifestations: active non-destructive polyarthritis, dermatitis, vasculitis of the skin, pleuritis. (bmj.com)
  • Acute and or chronic inflammatory course of vasculitis may causes severe neurological impairment or also death. (fortuneonline.org)
  • To determine whether you are disabled by lupus, the Social Security Administration first considers whether your lupus is severe enough to meet or equal a listing at Step 3 of the Sequential Evaluation Process . (vannuysdisability.com)
  • If your lupus is not severe enough to equal or meet a listing, the Social Security Administration must assess your residual functional capacity (RFC) (the work you can still do, despite your lupus), to determine whether you qualify for disability benefits at Step 4 and Step 5 of the Sequential Evaluation Process . (vannuysdisability.com)
  • Because of its species-restricted activity, it has not been possible to demonstrate antitumor activity in immunologically intact syngeneic tumor model systems, where effects on the host immune system would be observable. (drugs.com)
  • If a person does not respond well to steroid therapy, a doctor may prescribe cytotoxic drugs that stop the immune system cells that cause inflammation. (medicalnewstoday.com)
  • Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. (sncrf.org)
  • Lupus occurs when the immune system, which normally helps protect the body from infection and disease, attacks its own tissues. (iqscloud.net)
  • In CFS, the levels of neopterin, a marker of cellular immune system activation, IL-1 and TNF were correlated with fatigue and depression [ 84 ]. (healthrising.org)
  • Biological therapies, such as aldesleukin, use substances made from living organisms that may stimulate the immune system in different ways and stop tumor cells from growing. (survivornet.com)
  • 3 Immunohistochemical studies of an animal model with retinal vasculitis disclosed immune complex deposition within the vessel walls, which ultimately caused vaso-occlusion in the eye. (bmj.com)
  • [ 1 ] Some patients with SCLE may also have ACLE, if they have concomitant SLE, or the lesions of DLE and some may develop small-vessel vasculitis. (medscape.com)
  • Neonatal lupus is a passively acquired autoimmune disease that occurs in offspring of mothers with anti-SSA/Ro and/or anti-SSB/La antibodies. (heraldopenaccess.us)